Why is Syncom Formulations (India) Ltd ?
1
Company has a Debt to Equity ratio (avg) of 0.02 times
2
Poor long term growth as Net Sales has grown by an annual rate of -53.39% and Operating profit at -42.14% over the last 5 years
3
The company has declared Positive results for the last 9 consecutive quarters
- PAT(Latest six months) At Rs 50.02 cr has Grown at 49.75%
- ROCE(HY) Highest at 24.55%
- PBDIT(Q) Highest at Rs 26.21 cr.
4
With ROE of 18.4, it has a Expensive valuation with a 4.4 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 8.33%, its profits have risen by 48.7% ; the PEG ratio of the company is 0.4
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
6
Market Beating performance in long term as well as near term
- Along with generating 8.33% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Syncom Formul. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Syncom Formul. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Syncom Formul.
8.33%
0.20
40.89%
Sensex
-8.3%
-0.62
13.46%
Quality key factors
Factor
Value
Sales Growth (5y)
-53.39%
EBIT Growth (5y)
-42.14%
EBIT to Interest (avg)
30.08
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
9.88
Tax Ratio
24.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.35%
ROCE (avg)
80.28%
ROE (avg)
119.22%
Valuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
37
Price to Book Value
4.42
EV to EBIT
21.23
EV to EBITDA
19.60
EV to Capital Employed
5.67
EV to Sales
3.46
PEG Ratio
0.44
Dividend Yield
NA
ROCE (Latest)
23.35%
ROE (Latest)
18.41%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Movement
15What is working for the Company
PAT(Latest six months)
At Rs 50.02 cr has Grown at 49.75%
ROCE(HY)
Highest at 24.55%
PBDIT(Q)
Highest at Rs 26.21 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 20.88%
PBT LESS OI(Q)
Highest at Rs 24.42 cr.
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Syncom Formul.
Profit After Tax (PAT) - Latest six months
At Rs 50.02 cr has Grown at 49.75%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 26.21 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 24.42 cr has Grown at 40.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 17.44 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 20.88%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 24.42 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)






